cryptolepine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bierer, DE; Carlson, TJ; Fort, DM; Hobensack, C; Jolad, SD; King, SR; Lapresca, P; Luo, J; Mendez, CD; nii-Amon-Kotei, D; Noamesi, BK; Quan, J; Reaven, GM; Tsai, J; Waldeck, N | 1 |
1 trial(s) available for cryptolepine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent.
Topics: Adipose Tissue; Aged; Alkaloids; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Ethics, Pharmacy; Glucose; Humans; Hypoglycemic Agents; Indole Alkaloids; Indoles; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Middle Aged; Plants, Medicinal; Quinolines; Vasodilator Agents | 1998 |